Cargando…
Can Pretreatment Serum Beta-hCG be Used for Predicting Thyrotoxicosis in Gestational Trophoblastic Disease?
BACKGROUND: Gestational trophoblastic disease (GTD) comprises a diverse spectrum of entities of abnormal cellular proliferations originating in placental trophoblasts. The specific marker of GTD is beta-hCG which has a similar structure to the TSH molecule, interfering level of thyroid hormones. How...
Autores principales: | Khomphaiboonkij, Uraiwan, Termsarasab, Chanisorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068195/ https://www.ncbi.nlm.nih.gov/pubmed/34837900 http://dx.doi.org/10.31557/APJCP.2021.22.11.3461 |
Ejemplares similares
-
Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (β-hCG) with salvage chemotherapy
por: Feng, Fengzhi, et al.
Publicado: (2014) -
Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010) -
Beta-hCG expression by bladder cancers.
por: Iles, R.
Publicado: (1992) -
Hyperglycosylated-hCG: Its Role in Trophoblast Invasion and Intrauterine Growth Restriction
por: Herghelegiu, Catalin Gabriel, et al.
Publicado: (2023) -
Elevated serum beta-hCG due to a tumour of unknown origin.
por: Kenny, L., et al.
Publicado: (2004)